Elevation Oncology Cash Flow Statement 2020-2024 | ELEV

Fifteen years of historical annual cash flow statements for Elevation Oncology (ELEV).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$-45.70$-95.08$-32.04$-17.27
$-0.82$-0.18$0.02$0.02
$4.04$3.49$1.57$0.05
$3.21$3.31$1.59$0.07
$0$0$0$0
$0$0$0$0
$-5.86$0.71$-0.03$5.22
$-2.14$-0.61$-1.72$-1.28
$-13.69$6.29$0.28$4.90
$-56.18$-85.48$-30.17$-12.30
$0$-0.09$0$-0.07
$0$0$0$0
$0$0$0$0
$11.54$-44.31$0$0
$0$0$0$0
$11.54$-44.31$0$0
$0$0$0$0
$11.54$-44.40$0$-0.07
$0$30.00$0$0
$0$0$0$0
$0$30.00$0$0
$47.98$-0.02$97.06$0.02
$47.98$-0.02$97.06$90.20
$0$0$0$0
$0$-0.47$-0.01$-0.17
$47.98$29.51$97.05$90.03
$3.34$-100.37$66.88$77.66
$3.34$3.21$1.57$0.05
$0$0$0$0